The recent earnings call for ICON Plc presented a balanced perspective on the company’s performance. While there were notable achievements in business awards, cost management, and strategic ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma innovator, today announced its engagement with ICON Clinical Research Limited ("ICON") to expand it's Phase II Clinical Trial for ...